Participant flow18

How many started, completed or left each group, period by period.

1 to 18 of 18

Period	Milestone	Group	Participants
Double Blind	STARTED	Double Blind - Maralixibat	40
Double Blind	STARTED	Double Blind - Placebo	35
Double Blind	STARTED	Open Label - Maralixibat	0
Double Blind	COMPLETED	Double Blind - Maralixibat	28
Double Blind	COMPLETED	Double Blind - Placebo	24
Double Blind	COMPLETED	Open Label - Maralixibat	0
Double Blind	NOT COMPLETED	Double Blind - Maralixibat	12
Double Blind	NOT COMPLETED	Double Blind - Placebo	11
Double Blind	NOT COMPLETED	Open Label - Maralixibat	0
Open-Label	STARTED	Double Blind - Maralixibat	0
Open-Label	STARTED	Double Blind - Placebo	0
Open-Label	STARTED	Open Label - Maralixibat	52
Open-Label	COMPLETED	Double Blind - Maralixibat	0
Open-Label	COMPLETED	Double Blind - Placebo	0
Open-Label	COMPLETED	Open Label - Maralixibat	1
Open-Label	NOT COMPLETED	Double Blind - Maralixibat	0
Open-Label	NOT COMPLETED	Double Blind - Placebo	0
Open-Label	NOT COMPLETED	Open Label - Maralixibat	51

Source ClinicalTrials.govtrials-2026-11-12-0.5.0

Sources 3

ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
ClinicalTrials.govNo license stated
NIH RePORTER's clinical studies and project filesPublic domain

Each source's terms

ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
ClinicalTrials.govnone stated
NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Twenty rows a page, as JSON. No key.

GET https://conductscience.org/api/trials/v1/NCT04524390/flow